1. Hypertriglyceridaemia;Haymore;Hosp Physician,2005
2. NICE guidance for identification and treatment of familial hypercholesterolaemia: commentary 2;Durrington;Heart,2009
3. National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification. CG181. https://www.nice.org.uk/guidance/cg181 (Date of access: 15 May 2017).
4. Lipoprotein management in patients with cardiometabolic risk. Consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation;Brunzell;J Am Coll Cardiol,2008
5. National Institute for Health and Care Excellence (NICE) guidance for lipid management (https://www.england.nhs.uk/aac/publication/summary-of-national-guidance-for-lipid-management/) (Date of access: 16/12/2020).